Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The results with semaglutide alone are encouraging and suggest a potential new treatment option for a group of patients who previously had very few. The Phase II trial followed about 700 adults with biopsy-confirmed MASH and moderate to advanced liver scarring, including participants who had already developed early cirrhosis
The meaningful differences become apparent only when you look beyond the marketing language
Research indicates that not only are these diseases affecting more people, they are also starting earlier and resulting in more deaths than ever before
Hematology 23:653657
US$ 27.26
US$ 28.82
US$ 23.24
US$ 26.72
